BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17910769)

  • 1. Adherence to colorectal cancer screening guidelines in Canada.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    BMC Gastroenterol; 2007 Oct; 7():39. PubMed ID: 17910769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
    Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
    Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation in colorectal cancer screening: a review.
    Vernon SW
    J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in colorectal cancer screening: a guideline-based analysis of adherence.
    James TM; Greiner KA; Ellerbeck EF; Feng C; Ahluwalia JS
    Ethn Dis; 2006; 16(1):228-33. PubMed ID: 16599375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are physicians' recommendations for colorectal cancer screening guideline-consistent?
    Yabroff KR; Klabunde CN; Yuan G; McNeel TS; Brown ML; Casciotti D; Buckman DW; Taplin S
    J Gen Intern Med; 2011 Feb; 26(2):177-84. PubMed ID: 20949328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
    Seeff LC; Shapiro JA; Nadel MR
    J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood testing instructions and impact on patient adherence.
    Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
    Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation in colorectal cancer screening among Chinese Americans.
    Yip MP; Tu SP; Chun A; Yasui Y; Taylor VM
    Asian Pac J Cancer Prev; 2006; 7(4):645-50. PubMed ID: 17250445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.